glp-1 trial results today Lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating GLP1 agonists: current and future

Liver Load Increases GLP-1 drugs are metabolically active

Patients should never combine these medications without explicit guidance from their prescribing clinician , who can monitor for potential complications and adjust treatment plans accordingly

Peptide YY and other satiety peptides demonstrate clear physiological roles, with early failures attributable to rapid exposure and intolerance rather than to a lack of efficacy, again favoring re-evaluation

Commun Med

After 48 weeks treatment with two highest doses of retatrutide, 90% of participants had normalisation of liver fat [67]

OTC Option: Use an oral stimulant (Dulcolax pill) to force a movement in 6 to 12 hours, plus a softener to ease the strain